Literature DB >> 12147559

Pulmonary embolism and pneumonia may be confounded after acute stroke and may co-exist.

James Kelly1, Beverley J Hunt, Anthony Rudd, Roger R Lewis.   

Abstract

Pulmonary embolism and pneumonia are prevalent complications after acute stroke that overlap significantly in their timing, risk factors and clinical features. Consequently, confounding and co-existence of these diagnoses can occur and is probably commoner than is generally appreciated. Correct identification of pulmonary embolism in these patients is important as the mortality of this condition following stroke is higher than in unselected patients. Clinicians should have a low threshold for suspicion of, and objective testing for, pulmonary embolism in stroke patients with acute cardiorespiratory symptoms, even if an alternative diagnosis is evident.

Entities:  

Mesh:

Year:  2002        PMID: 12147559     DOI: 10.1093/ageing/31.4.235

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  4 in total

1.  European Stroke Organisation (ESO) guidelines for prophylaxis for venous thromboembolism in immobile patients with acute ischaemic stroke.

Authors:  Martin Dennis; Valeria Caso; L Jaap Kappelle; Aleksandra Pavlovic; Peter Sandercock
Journal:  Eur Stroke J       Date:  2016-03-01

2.  Clustering patterns of comorbidities associated with in-hospital death in hospitalizations of US adults with venous thromboembolism.

Authors:  James Tsai; Althea M Grant; J Michael Soucie; Amy Helwig; Hussain R Yusuf; Sheree L Boulet; Nimia L Reyes; Hani K Atrash
Journal:  Int J Med Sci       Date:  2013-08-19       Impact factor: 3.738

3.  Predictive accuracy of 29-comorbidity index for in-hospital deaths in US adult hospitalizations with a diagnosis of venous thromboembolism.

Authors:  James Tsai; Karon Abe; Sheree L Boulet; Michele G Beckman; W Craig Hooper; Althea M Grant
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

4.  Pulmonary embolism in ischemic stroke: clinical presentation, risk factors, and outcome.

Authors:  Jitphapa Pongmoragot; Alejandro A Rabinstein; Yongchai Nilanont; Richard H Swartz; Limei Zhou; Gustavo Saposnik
Journal:  J Am Heart Assoc       Date:  2013-11-25       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.